High agreement of routine cytopathology and immunocytochemistry in canine lymphomas

• Autorzy: Sapierzynski R. , Dolka I. , Fabisiak M.
• Języki publikacji: EN

Abstrakty

EN

The aim of this study was to compare the concordance of immunophenotype established with routine cytopathology (slides stained with Giemsa solution) and immunocytochemistry according to CD3 and CD79 alpha immunoreactivity. The study was performed on cytological samples of 70 canine lymphomas subtyped on the basis of the updated Kiel classification system. Additionally, cytologic samples were examined immunocytochemically for the CD3 and CD79 alpha antigens presence and thus immunophenotype of neoplastic growth was confirmed. The cytopathological and immunocytochemical diagnoses were then compared; in order to measure the concordance between immunocytochemistry (IC) result and Giemsa stain result of the same sample the Cohen's kappa coefficient was calculated. On the basis of the results of immunocytochemistry of 70 cases of canine lymphoma examined 42 were recognized as B cell lymphoma and 28 as T cell lymphoma. Full accordance between the results of routine cytopathology and IC was obtained in 63 out of 70 examined dogs (90% of cases). It can be concluded that cytopathological examination of Giemsa stained smears is helpful in determining the lymphoma cells immunophenotype. Additionally, it seems that combination of routine cytopathology and immunocytochemistry in cases of canine lymphomas allows to obtain the precise diagnosis in 90% of cases, and allows to receive most important information that is necessary for planning of appropriate therapy and to determine prognosis. Finally, this routine procedure allowed to eliminate the need of collection of tissue samples during surgery or core-biopsy and thus time, cost and patient discomfort related to more complex and invasive medical procedures can be easily reduced.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2012
• Tom: 15
• Numer: 2
• Opis fizyczny: p.247-252,ref.

Twórcy

autor

Sapierzynski R.

• Department of Pathology and Veterinary Diagnostic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Nowoursynowska 159c, 02-776 Warsaw, Poland

autor

Dolka I.

autor

Fabisiak M.

Bibliografia

• Alam K, Jain A, Maheshwari V, Siddiqui FA, Haider N, Khan AH (2010) Fine-needle aspiration cytology diagnosis of non-Hodgkins lymphoma in a resource-challenged environment. Diagn Cytopathol 39: 461-467.
• Altman DG (1991) Practical Statistics for Medical Research, 1st ed., Chapman and Hall, London.
• Caniatti M, Roccabianca P, Scanziani E, Paltrinieri S, Moore PF (1996) Canine lymphoma: immunocytochemical analysis of fine-needle aspiration biopsy. Vet Pathol 33: 204-212.
• Comazzi S, Gelain ME (2011) Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma. Vet J 188: 149-155.
• Comazzi S, Galain ME, Martini V, Riondato F, Miniscalco B, Marconato L, Stefanello D, Mortarino M (2011) Immunophenotype predicts survival time in dogs with chronic lymphocytic leukemia. J Vet Intern Med 25: 100-106.
• Das DK (1999) Value and limitations of fine-needle aspiration cytology in diagnosis and classification of lymphomas: A review. Diagn Cytopathol 21: 240-249.
• Dzimira S (2007) Immunocytochemical and cytomorphometric diagnostics of malignant lymphomas in dogs. Bull Vet Inst Pulawy 51: 71-78.
• Everitt BS (1989) Statistical Methods for Medical Investigations, 1st ed., Oxford University Press, London. Fisher DJ, Naydan D, Werner LL, Moore PF (1995) Immunophenotyping lymphomas in dogs: a comparison of results from fine needle aspirate and needle biopsy samples. Vet Clin Pathol 24: 118-123.
• Fleiss JL, Levin B and Paik MC (2003) Statistical Methods for Rates and Proportions, 3rd ed., John Wiley, Hoboken. Fournel-Fleury C, Magnol JP, Bricaire P, Marchal T, Chabanne L, Delverdier A, Bryon P.A., Felman P (1997)
• Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin’s lymphomas. J Comp Pathol 117: 35-59.
• Fournel-Fleury C, Ponce F, Felman P, Blavier A, Bonnefont C, Marchal T, Cadore JL, Goy-Thollot I, Ledieu D, Ghernati I, Magnol JP (2002) Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Vet Pathol 39: 92-109.
• Gibson D, Aubert I, Woods JP, Abrams-Ogg A, Kruth S, Wood RD, Bienzle D (2004) Flow cytometric immunophenotype of canine lymph node aspirates. J Vet Intern Med 18: 710-717.
• Guija de Arespacochaga A, Schwendenwein I, Weissenbock H (2007) Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping. J Comp Pathol 136: 186-192.
• Jagielski D, Lechowski R, Hoffman-Jagielska M, Winiarczyk S (2002) A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000). J Vet Med A 49: 419-424.
• Jubala CM, Wojcieszyn JW, Valli VE, Getzy DM, Fosmire SP, Coffey D, Bellgrau D, Modiano JF (2005) CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma. Vet Pathol 42: 468-476.
• Lana S, Plaza S, Hampe K, Burnett R, Avery AC (2006) Diagnosis of mediastinal masses in dogs by flow cytometry. J Vet Intern Med 20: 1161-1165.
• Marconato L (2011) The staging and treatment of multicentric high-grade lymphoma in dogs: a review of recent developments and future prospects. Vet J 188: 34-38.
• Marconato L, Stefanello D, Valenti P, Bonfanti U, Comazzi S, Roccabianca P, Caniatti M, Romanelli G, Massari F, Zini E (2011) Predictors of long-term survival in dogs with high-grade multicentric lymphoma. J Am Vet Med Assoc 238: 480-485.
• Pastor M, Chalvet-Monfray K, Marchal T, Keck G, Magnol JP, Fournel-Fleury C, Ponce F (2009) Genetic and environmental risk indicators in canine non-Hodgkin’s lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year. J Vet Intern Med 23: 301-310.
• Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray K, Fournel-Fleury C (2004) Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Vet J 167: 158-166.
• Sapierzyński R (2010) Practical aspects of immunocytochemistry in canine lymphomas. Pol J Vet Sci 13: 661-668.
• Sapierzyński R, Micuń J, Jagielski D, Jurka P (2010) Cytopathology of canine lymphomas (100 cases). Pol J Vet Sci 13: 653-659.
• Sokołowska J, Cywińska A, Malicka E (2005) p53 expression in canine lymphoma. J Vet Med A 52: 172-175.
• Sozmen M, Tasca S, Carli E, De Lorenzi D, Furlanello T, Caldin M (2005) Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas. J Vet Diagn Invest 17: 323-330.
• Sueiro FA, Alessi AC, Vassallo J (2004) Canine lymphomas: a morphological and immunohistochemical study of 55 cases, with observations on p53 immunoexpression. J Comp Pathol 131: 207-213.
• Teske E, van Heerde P (1996) Diagnostic value and reproducibility of fine-needle aspiration cytology in canine malignant lymphoma. Vet Q 18: 112-115.
• Vail DM, Kravis LD, Kisseberth WC, Ogilvie GK, Volk LM (1997) Application of rapid CD3 immunophenotype analysis and argyrophilic nucleolar organizer region (Ag-NOR) frequency to fine needle aspirate specimens from dogs with lymphoma. Vet Clin Pathol 26: 66-69.
• Vail DM, Young KM (2007) Canine lymphoma and lymphoid leukemia. In: Withrow SJ, Vail DM (eds) Withrow and MacEwen’s Small Animal Clinical Oncology, 4th ed., Saunders Elsevier, St Louis, pp 699-733.
• Valli VE, San Myint M, Barthel A, Bienzle D, Caswell J Colbatzky F, Durham A, Ehrhart EJ, Johnson Y, Jones C, Kiupel M, Labelle P, Lester S, Miller M, Moore P, Moroff S, Roccabianca P, Ramos-Vara J, Ross A, Scase T, Tvedten H, Vernau W (2011) Classification of canine malignant lymphomas according to the World Health Organization Criteria. Vet Pathol 48: 198-211.
• Williams MJ, Avery AC, Lana SE, Hillers KR, Bachand AM, Avery PR (2008) Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. J Vet Intern Med 22: 596-601

Uwagi

Rekord w opracowaniu